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Conclusions Galactose thus presents the interesting char-
acteristics of a low-glycemic sugar with mild cardiovas-
cular effects. Further studies are warranted to conﬁrm the 
clinical relevance of the milder cardiovascular effects of 
galactose than other sugars for insulin resistant obese and/
or diabetic patients with cardiac insufﬁciency.
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Introduction
A rise in the consumption of reﬁned sugars in food and bev-
erages has often been implicated in the epidemic of obesity, 
type 2 diabetes and cardiovascular diseases. While most 
added sugars are consumed as the disaccharide sucrose or 
in the form of its two constituent monosaccharides (glu-
cose and fructose), it is its fructose moiety which, despite 
its classiﬁcation as a low-glycemic sugar, is viewed as the 
more harmful sugar component [1].
Indeed, chronic studies comparing diets containing fruc-
tose in substitution for glucose have demonstrated a more 
adverse lipid proﬁle and greater cardiometabolic risks [1, 
2].
During the past decade, there has been increasing inter-
est in the potential beneﬁcial effects of galactose [3–10], a 
low-glycemic sugar monosaccharide which in combination 
with glucose constitutes the disaccharide lactose. Although 
galactose is absorbed at the same rate as glucose, most of 
it is taken up by the liver where it is metabolized to other 
substrates (glucose, lactate or fatty acids) that are readily 
metabolized by extrahepatic cells [11]. Consequently, as the 
release of galactose in the form of glucose into the blood is 
delayed, it could provide an energy source of choice with 
Abstract 
Purpose There is increasing interest into the potentially 
beneﬁcial effects of galactose for obesity and type 2 dia-
betes management as it is a low-glycemic sugar reported to 
increase satiety and fat mobilization. However, fructose is 
also a low-glycemic sugar but with greater blood pressure 
elevation effects than after glucose ingestion. Therefore, 
we investigated here the extent to which the ingestion of 
galactose, compared to glucose and fructose, impacts upon 
haemodynamics and blood pressure.
Methods In a randomized cross-over study design, 9 
overnight-fasted young men attended 3 separate morning 
sessions during which continuous cardiovascular monitor-
ing was performed at rest for at least 30 min before and 
120 min after ingestion of 500 mL of water containing 
60 g of either glucose, fructose or galactose. These meas-
urements included beat-to-beat systolic and diastolic blood 
pressure, heart rate deduced by electrocardiography, and 
stroke volume derived by impedance cardiography; these 
measurements were used to calculate cardiac output and 
total peripheral resistance.
Results Ingestion of galactose, like glucose, led to signiﬁ-
cantly lesser increases in systolic, diastolic and mean blood 
pressure than fructose ingestion (p < 0.05). Furthermore, 
the increase in cardiac output and reduction in total periph-
eral resistance observed after ingestion of glucose were 
markedly lower after galactose ingestion (p < 0.01).
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a low-glycemic index and a low-insulinemic response [12–
15]. Indeed, several studies in healthy humans have shown 
that the ingestion of galactose elicits only small increases 
in plasma glucose and insulin, which are not different from 
those in response to fructose ingestion [12–15].
This speciﬁc metabolic fate of galactose has formed the 
basis of interest in this low-glycemic sugar with respect to 
its potential impact on exercise performance [5, 8, 10] and 
more recently for weight control [3, 4, 6, 7, 9, 10]. In the 
latter context, several acute studies have shown that inges-
tion of galactose leads to increased satiety [3, 4, 10]. Further-
more, a chronic study involving intermittent intake of sug-
ary drinks in women has shown that intake of galactose in 
substitution for glucose resulted in increased fat mobilization 
and oxidation [6], which would be consistent with the much 
lesser impact of galactose than glucose ingestion on circulat-
ing insulin [12–15]. These studies have led to the proposal 
that diets with galactose as a source of carbohydrates could 
be useful in the management of obesity and type 2 diabetes.
Little is known, however, about the impact of galactose 
ingestion on the cardiovascular system. By contrast, it has 
repeatedly been demonstrated that the ingestion of glucose 
and fructose drinks is characterized by speciﬁc haemody-
namic responses in healthy young [16, 17] and older people 
[18]. Unlike drinking glucose, which decreases total periph-
eral resistance by an insulin-mediated release of nitric oxide 
accompanied by a metabolic vasodilation leading to an 
increase in cardiac output (CO), thereby resulting in little or 
no change in blood pressure (BP), the ingestion of fructose 
elicits a signiﬁcant increase in BP that results from a more 
modest increase in CO but without a decrease in TPR [16, 
17]. These differential BP responses to glucose and fructose 
ingestion have been attributed to their differential effects on 
insulin secretion [17], and to the well-known effect of insu-
lin not only in enhancing sympathetic activation of cardiac 
contractility (hence contributing to the increased CO) [19], 
but also in stimulating peripheral vasodilatation and hence 
decreasing TPR [20]. In this context, the question arises as to 
whether ingestion of galactose, which like fructose has only 
a mild stimulatory effect on insulin release [12–15], would 
also lead to higher BP. In testing this hypothesis, the aim of 
our study here was to investigate, using comprehensive and 
continuous cardiovascular monitoring, potential differences 
in BP and haemodynamics between galactose, glucose and 
fructose in a cross-over study design in young men.
Methods
Subjects
Nine healthy young men aged 24 ± 1 year (mean ± SD) 
were recruited from local students and their friends. The 
mean height of the participants was 182 ± 7 cm, body 
weight was 79 ± 13 kg and BMI was 23.8 ± 2.8 kg/
m2. Before their ﬁrst test, subjects had to ﬁll out a ques-
tionnaire about their health and lifestyle and under-
went BP and anthropometric measurements to ensure a 
healthy condition. We deﬁned healthy on the basis that 
all of our test subjects were non-obese with normal rest-
ing BP (brachial systolic/diastolic BP < 140/90 mmHg 
and >100 mmHg systolic BP) and none of our subjects 
had any diseases or were taking any medication affect-
ing cardiovascular regulation. All participants fasted for 
≥12 h and abstained from alcohol, smoking and caffeine 
as well as from vigorous exercise for 24 h prior to each 
test and were advised not to change their dietary habits 
between the tests. This study was conducted according to 
the guidelines laid down in the Declaration of Helsinki, 
all procedures involving human subjects were approved 
by the Cantonal Ethics Committee, and written informed 
consent was obtained from all subjects prior to their inclu-
sion in the study.
Experimental design
All studies started between 08:00 and 09:00 in a quiet, 
air-conditioned laboratory (21 °C), with the subjects at 
thermal comfort. Every test subject attended three sepa-
rate experimental sessions (separated by at least 2 days) 
according to a randomized cross-over design. Randomi-
zation was performed using a random sequence gen-
erator (https://www.randomizer.org/) where the sessions 
order was determined for 9 test subjects before the study 
started. At each experimental session, the cardiovascu-
lar responses to one of three drinks were monitored. The 
drinks tested were as follows: (1) water containing 60 g 
of D(+)-glucose, (2) water containing 60 g of D(+)-
galactose, and (3) water containing 60 g D(−)-fructose. 
The purity of all sugars was 99 % (Argos Organics, Che-
mie Brunschwig SA, Basel, Switzerland). Each drink also 
contained 10 mL lemon juice (to mask the difference in 
sweetness) and was made up to a total of 500 mL by addi-
tion of distilled water (21 °C). The subjects were not told 
the order of the drinks.
On arrival at the laboratory, subjects were asked to 
empty their bladders if necessary and to sit in a com-
fortable armchair. After waiting for a 20–30 min period 
to attain cardiovascular stability, continuous beat-by-
beat recordings were initiated starting with at least a 
30-min baseline period after which the subject ingested 
the respective test drink over a period of 4 min, which 
was followed by post-drink cardiovascular recordings 
over the next 120 min. The subjects were allowed to 
watch documentaries and calm movies in order to reduce 
boredom.
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Haemodynamics
A Task Force Monitor (CNSystems, Medizintechnik, Graz, 
Austria) was used to perform cardiovascular recordings, 
and data were sampled at a rate of 1000 Hz [21]. Con-
tinuous BP was monitored using the Penaz principle from 
either the index or middle ﬁnger (automatically ﬁnger 
switch every 30 min) of the right hand and was calibrated 
to oscillometric brachial BP measurements on the con-
tralateral arm. The right hand with the continuous BP cuff 
rested on a ductile pillow which was positioned at heart 
level on a height adjustable table. Impedance cardiogra-
phy measurements [22], in which the changes in thoracic 
impedance are converted to reﬂect changes in thoracic ﬂuid 
content/volume over time, were taken based on the original 
Kubicek [23] approach, but using an improved estimate of 
thoracic volume [24], which allows calculation of cardiac 
stroke volume (SV). ECG/impedance electrodes were posi-
tioned together with upper arm and ﬁnger BP cuffs. Elec-
trode strips were placed at the neck and thoracic regions, 
the latter speciﬁcally at the midclavicular at the xiphoid 
process level (CNSystems standard electrode kits).
Statistical analysis
Values of cardiac interval, systolic BP (SBP), diastolic 
BP (DBP) and SV were averaged every 20 min during the 
baseline period and the 120 min post-drink period. CO was 
derived as the product of SV and heart rate (HR), where HR 
was calculated from the appropriate cardiac interval. Total 
peripheral resistance (TPR) was calculated as mean BP 
(MBP) divided by CO, where MBP was calculated as the 
result of DBP + 1/3 (SBP–DBP). All values are reported as 
mean ± SD. Statistical analysis was performed by two-way 
ANOVA for repeated measures with time and treatment of 
sugar-type (glucose, galactose, fructose) as within-subject 
factors using statistical software (Statistix version 8.0; Ana-
lytical Software, St. Paul, MN). Where signiﬁcant differ-
ences were found, the effects of each drink over time were 
analysed by comparing values at each time point over the 
post-drink period with the basal values recorded before 
drinking. One-way ANOVA with Dunnett’s multiple com-
parison test and repeated-measures ANOVA with Newman-
Keuls post hoc testing were used to test for changes over 
time from baseline level and to compare mean changes 
between the drink types. All reported p values are two-
sided. For all tests, signiﬁcance was set at p ≤ 0.05.
Sample size
Our sample size is based on the results of our previous 
study [16], comparing BP responses to glucose and fruc-
tose. Assumptions are (1) a clinically relevant difference 
of 5 mmHg between galactose and fructose in healthy 
subjects (averaged response over 120 min post-drink) and 
(2) a standard deviation of the difference in post-drink BP 
response of 5 mmHg. Therefore, using a type I error (α) of 
0.05 and a desired power (1−β) of 0.80, such an investi-
gation of repeated measures (on the same subject) would 
require a total number of 8 subjects.
Results
Blood pressure
For all cardiovascular parameters assessed, there were no 
signiﬁcant differences in the baseline values across days 
(Table 1).
The BP responses to the sugary drinks are shown in 
Fig. 1 (panels a–c). In response to all three sugary drinks, 
SBP increased gradually to reach a plateau within an hour, 
and the signiﬁcantly higher SBP values were maintained 
until the end of the study, i.e. 120 min post-drink. ANOVA 
indicates a signiﬁcant effect of sugar-type (p < 0.05), with 
the increase in SBP in response to fructose (7–8 mmHg) 
being greater than after glucose (4–5 mmHg) or galac-
tose (2–3 mmHg). A signiﬁcant effect of sugar-type has 
also been found in the DBP response (p < 0.05). As shown 
in Fig. 1 (panel b), DBP was also found to be increased 
to a greater extent with fructose, reaching a plateau of 
~5 mmHg relative to baseline (p < 0.05), compared to 
Table 1  Baseline 
haemodynamic data before 
ingestion of the sugary drinks, 
each ingested as 500 mL of 
distilled water containing 60 g 
glucose, galactose or fructose
All data are presented as mean ± SD. Baseline haemodynamic parameters for glucose, galactose and fruc-
tose were compared using one-way ANOVA
Sugary drink Glucose Galactose Fructose p value
Systolic blood pressure (mmHg) 122.2 ± 8.9 121.1 ± 11.5 121.0 ± 10.2 0.843
Diastolic blood pressure (mmHg) 76.9 ± 6.9 75.1 ± 8.4 76.7 ± 8.2 0.541
Heart rate, beats (min−1) 58.4 ± 9.3 61.5 ± 11.1 60.9 ± 9.5 0.294
Stroke volume (mL) 91.1 ± 15.7 94.2 ± 23.8 90.0 ± 20.8 0.588
Cardiac output (L min−1) 5.3 ± 0.8 5.6 ± 0.7 5.4 ± 1.0 0.124
Total peripheral resistance (mmHg L−1 min) 17.8 ± 2.3 16.3 ± 2.1 17.5 ± 3.1 0.098
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non-signiﬁcant increases of only 2–3 mmHg in response 
to glucose or galactose. These more pronounced increases 
in SBP and DBP in response to fructose than to glucose 
or galactose are reﬂected in MBP (Fig. 1, panel c), which 
showed, in the plateau phase, increases of about 6 mmHg 
for fructose compared to only a 3 mmHg increase for glu-
cose or galactose (ANOVA: p < 0.05). Pair-wise compari-
sons across the sugars for the average increases in BP over 
Fig. 1  Time course of changes in systolic blood pressure (SBP) a, 
diastolic blood pressure (DBP) b and mean blood pressure (MBP) 
(C) before and after ingestion of glucose (open circle), galactose 
(closed square) and fructose (closed triangle). Repeated-measures 
ANOVA assessed statistical differences as follows: effect of time 
(symbol dagger), effect of Sugar-type (symbol @) and the Sugar-
type × time interaction (symbol double dagger); one, two and three 
symbols denoting p < 0.05, p < 0.01 and p < 0.001, respectively. For 
data on post-drink changes averaged over 60 and 120 min (shown as 
bars), post hoc pair-wise comparison for statistical differences across 
sugar-types is assessed by Dunnett’s multiple comparison tests and 
indicated as follows: *p < 0.05, **p < 0.01 and ***p < 0.001. Signiﬁ-
cant difference between post-drink and baseline values are indicated 
as follows: NS non-signiﬁcant; °p < 0.05, °°p < 0.01 and °°°p < 0.001
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the 120 min (or ﬁrst 60 min) post-drink indicate that SBP, 
DBP and MBP are all signiﬁcantly different between fruc-
tose versus glucose or between fructose versus galactose, 
but not between glucose versus galactose.
Heart rate and stroke volume
While all sugars increased HR reaching plateau values 
between 60 and 90 min post-drink (Fig. 2, panel a), a sig-
niﬁcant interaction effect of sugar-type and time (ANOVA, 
p < 0.001) is observed, with fructose ingestion resulting in 
the greatest elevation in HR (+7 bpm) in the second hour 
post-drink compared to glucose (+4–5 bpm) or galactose 
(+2–3 bpm). In contrast, fructose ingestion, like galac-
tose ingestion, did not signiﬁcantly increase SV (Fig. 2, 
panel b), while glucose increased SV with peak values 
(+8–12 mL) between 15 and 45 min post-drink; the effect 
of sugar-type for SV is statistically signiﬁcant, particularly 
during the ﬁrst hour post-drink (p < 0.01).
Cardiac output and total peripheral resistance
The increase in BP in response to the fructose drink was 
accompanied by a modest increase in CO (Fig. 2, panel c) 
which reached a plateau after 45 min (Δ = 0.5 L/min), but 
with no change in TPR (Fig. 2, panel d). This contrasts with 
the response to glucose, showing a signiﬁcantly greater 
increase in CO, particularly during the ﬁrst 60 min post-
drink (Δ = 0.80–1.0 L/min), but also a signiﬁcant decrease 
in TPR over that same time period before returning gradu-
ally towards baseline levels. In response to galactose, CO 
also increased, albeit to a much lesser extent than after glu-
cose, reaching a plateau which was maintained between 30 
and 90 min post-drink (Δ ~ 0.35 L/min), and this plateau 
value after galactose tended to be lower and less sustained 
than that for fructose. This was accompanied by a small 
decline in TPR during 15–30 min post-drink before a return 
to baseline levels; this decline in TPR being much less pro-
nounced than with glucose.
Discussion
This study compared acute cardiovascular responses of 
three dietary monosaccharides, galactose, glucose and fruc-
tose, in a randomized cross-over design. Our results conﬁrm 
the greater impact of fructose than glucose on BP and also 
demonstrate that the BP-elevating effect of fructose is not 
mimicked by galactose ingestion. Furthermore, we show 
here that the increase in CO, as well as the decrease in TPR 
in response to glucose, is much less pronounced if com-
pared to galactose ingestion. Galactose therefore combines 
the advantages of a low-glycemic index sugar with mild car-
diovascular effects compared to fructose or glucose.
To our knowledge, only one study has previously exam-
ined acute BP responses to galactose in comparison with 
glucose and fructose. It was reported that SBP was not 
altered after galactose or fructose, but transiently increased 
(1–2 h) after glucose and that DBP was not altered by any 
of these three sugars [13]. The interpretation of this study’s 
data is, however, limited for several reasons: (1) a higher 
baseline value was observed for fructose (118–121 mmHg) 
than for glucose and galactose (111–114 mm Hg), which 
could hence contribute to the inability to demonstrate an 
increase in BP after fructose ingestion, (2) all of their sub-
jects experienced watery diarrhoea after ingestion of fruc-
tose (1 g/kg), most of them within 40–60 min post-drink, 
(3) the consumption of a large distilled water preload 
(>1 L) 2 h before the sugary drinks may also be an inter-
fering factor in the cardiovascular responses after the sug-
ary drinks and (4) BP was monitored by discontinuous 
oscillometric method and measured only once every hour. 
In the current study, in which we performed continuous 
beat-by-beat measurement of BP in response to the sugary 
drinks, we are able to conﬁrm the BP-elevating effects of 
fructose observed in two previous studies in our laboratory 
using a similar experimental protocol and sugar load (60 g 
in 0.5 L water) [16, 17], namely a greater and sustained 
increase over at least 90 min in both SBP and DBP after 
fructose than after glucose ingestion. In these latter stud-
ies, glucose led to marginal or no increase in BP similar 
to that observed in the present studies after glucose and 
galactose. Moreover, based upon our previous observations 
[16, 21] that SBP tended to increase by a few mmHg over 
1–2 h after a 0.5 L water load, our ﬁndings here of a small 
gradual increase in BP after glucose or galactose ingestion 
could be largely attributed to the water-load component of 
the sugar drinks rather than an effect of these sugars per 
se. Overall, in previous studies from our laboratory [16, 17] 
and in the present study, the BP response to fructose was 
found to be signiﬁcantly greater than that after glucose by 
3–4 mmHg. Furthermore, no differences are observed here 
between galactose and glucose in BP, whether SBP, DBP 
or MBP, and unexpectedly the ingestion of galactose, com-
pared to glucose ingestion, resulted in a lesser effect with 
marginal impact on HR, SV and CO.
According to classic theory linking diet to BP regulation 
[19], the presence of macronutrients (particularly carbohy-
drates) in the diet would lead to increased circulating insu-
lin levels, which can act centrally to stimulate sympathetic 
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neural activity to the heart resulting in increased HR and 
CO. However, as insulin also possesses potent vasodilatory 
properties in skeletal muscle micro- and macro-vasculature 
[20], which are believed to contribute importantly to glu-
cose clearance by this tissue, the resulting insulin-induced 
decrease in TPR would largely compensate for its central 
sympathetic stimulatory effects on the heart, thereby result-
ing in marginal or no increase in BP. The contrasting vas-
cular responses to fructose and glucose ingestion might 
therefore be explained, at least in part, by the haemody-
namic actions of insulin. Whether, in our present study, the 
decrease in TPR observed after galactose, albeit much less 
pronounced than after glucose, involves peripheral vasodila-
tors distinct from insulin remains an intriguing question.
Our study has a number of limitations. First, we did 
not take venous blood samples in order to assess insulin 
and glucose values because the cannulation process could 
inﬂuence the subtle haemodynamic changes that are being 
monitored [25]. However, as summarized in Table 2, sev-
eral past studies comparing postprandial glucose and 
Fig. 2  Time course for changes of heart rate (HR) (A), stroke vol-
ume (SV) (B), cardiac output (CO) (C) and total peripheral resist-
ance (TPR) (D), before and after ingestion of glucose (open circle), 
galactose (closed square) and fructose (closed triangle). Repeated-
measures ANOVA assessed statistical differences as follows: effect of 
time (symbol dagger), effect of sugar-type (symbol @) and the sugar-
type × time interaction (symbol double dagger); one, two and three 
symbols denoting p < 0.05, p < 0.01 and p < 0.001, respectively. For 
data on post-drink changes averaged over 60 and 120 min (shown as 
bars), post hoc pair-wise comparison for statistical differences across 
sugar-types is assessed by Dunnett’s multiple comparison tests and 
indicated as follows: *p < 0.05, **p < 0.01 and ***p < 0.001. Sig-
niﬁcant difference between post-drink and baseline values are indi-
cated as follows: NS non-signiﬁcant; °p < 0.05; °°p < 0.01; and 
°°°p < 0.001)
Table 2  Summary of studies reporting plasma insulin and glucose before and after ingestion of a sugary drink
Glc glucose. Values for plasma insulin and glucose levels were either obtained from tables or estimated from ﬁgures. A conversion factor of 
0.555 was used to convert mg/dL to mmol/L in the study by Williams et al. [31]. Data from the study by Ganda et al. [12] have been reported for 
not more than 30 min post-drink
Study Sugar-type Subjects Drink Baseline insulin 
(μU/mL)
Baseline glucose 
(mmol/l)
Δ Insulin  
(μU/mL)
Δ Glucose 
(mmol/L)
Blaak [26] Glucose (75 g)
Fructose (75 g)
10 men 400 mL lemon 
ﬂavoured 
water
9
9
4.8
4.8
44
7
1.3
0.1
Rebello [13] Glucose (1 g/kg BW)
Fructose (1 g/kg BW)
Galactose (1 g/kg BW)
20 women 20 mL water 
per kg BW
22
29
24
4.4
4.4
4.5
73
7
8
1.7
0.2
0.0
Fukagawa [27] Glucose (75 g)
Fructose (75 g)
6 men–2 
women
500 mL lemon 
ﬂavoured 
water
5
5
4.4
4.4
60
12
3.2
0.9
Münstedt [28] Glucose (75 g)
Fructose (75 g)
15 men Total volume of 
300 mL
4.5
6.5
5.1
4.1
45
10
1.0
0.7
Schwarz [29] Glucose (75 g)
Fructose (75 g)
10 men–10 
women
Total volume of 
200–300 mL
12
12
4.8
4.8
95
22
2.6
0.4
Tappy [30] Glucose (75 g)
Fructose (75 g)
10 Total volume of 
300 mL
8
8
5.1
5.1
50
10
3.8
0.9
Ganda (12) Glucose (50 g)
Galactose (50 g)
Fructose (50 g)
10 men Total volume of 
150 mL
7.5
7.5
9.0
4.2
4.4
4.4
51
20
13
2.9
0.6
0.4
Williams [31] Gal A (0.5 g/kg, n = 11)
Gal B (0.5 g/kg, n = 11)
Gal C (0.5 g/kg, n = 6)
20 men–11 
women
Sugars dis-
solved in 
4 mL of water 
per kg BW
7
10
8
4.1
4.4
4.6
12.3
6
7.8
0.2
0.3
0.2
Coss-Bu [14] Galactose (~50 g)
Fructose (~45 g)
3 men–3 
women
Prior infusion 
of ~120 mg 
Glc in 8 h
Water added?
5.3
7.1
4.8
4.4
9.0
11.2
0.4
0.4
Sunehag and 
Hamond [15]
Galactose 
(11 μmol kg−1
 min−1)
Galactose plus glucose 
(11 μmol kg−1 min−1, 
respectively)
5 females Ingestion over 
120 min
3.7
5.0
4.7
5.0
3.2
9.3
0.3
0.6
◂
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insulin responses to these monosaccharides (in amounts 
similar to those used in our study here) have consistently 
shown markedly lower rise in circulating glucose and insu-
lin following fructose and galactose than after glucose 
[12–15, 26–31]. Second, our study was conducted only in 
men. In this ﬁrst “proof-of-concept” study about the cardi-
ovascular impact of galactose, we focused on men because 
including women would have increased substantially the 
number of subjects and testing days (cross-over design) in 
order to observe a potential gender effect with sufﬁcient 
statistical power. Third, based on our selective study pop-
ulation, which included only young and healthy men of 
normal body weight, our ﬁndings cannot be extrapolated 
to the general population. Further studies are warranted to 
explore the proof-of-concept presented here of a favour-
able haemodynamic proﬁle of galactose (besides its low-
glycemic index) in patients with cardiac insufﬁciency and 
impaired glucose metabolism (i.e. impaired glucose toler-
ant patients and/or type 2 diabetic patients).
In conclusion, this study demonstrates that galactose 
resembles glucose in its marginal impact on BP, which 
contrasts with the signiﬁcant BP-elevating effect of fruc-
tose ingestion. Furthermore, it has a much less pronounced 
effect on cardiac workload than glucose. Galactose thus 
presents the interesting characteristics of a low-glycemic 
sugar with mild cardiovascular effects. Further studies are 
warranted to conﬁrm the clinical relevance of the milder 
cardiovascular effects of galactose compared to other sug-
ars for insulin resistant obese and/or diabetic patients with 
cardiac insufﬁciency and also to investigate whether this 
beneﬁcial cardiac effect of galactose would persist when 
consumed together with other monosaccharides (i.e. glu-
cose, fructose or sucrose), as well as when integrated in 
meals in more chronic studies.
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